An HIV drug failed to help patients with severe cases of COVID-19, according to disappointing results from one of the first coronavirus drug trials (ABBV)
Business Insider -

REUTERS/Tobias Schwarz

Some of the first clinical data for a potential coronavirus treatment showed it did not help patients with severe cases of COVID-19, the disease caused by the coronavirus pandemic. 

Scientists in China enrolled 199 coronavirus patients into a study from January 18 through February 3, randomly assigning them to get either the HIV drug Kaletra plus standard of care, or just regular care. 

The drug did not show benefits in keeping patients alive, reducing the amount of virus...

Read this story at


Related Articles